Luisa Verga

Azienda Ospedaliera San Gerardo — Italy

Medicine · Health Sciences

18h-index1.3kcitations90works3.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(28), Chronic Lymphocytic Leukemia Research(27), Antifungal resistance and susceptibility(19), Neutropenia and Cancer Infections(19), Viral-associated cancers and disorders(17)

Publications90 total

Lessons from the IELSG45 trial: The impact of patient fitness on dropout rate in primary central nervous system lymphoma (PCNSL) studies
Blood·2025
287 | SHORT‐TERM DOSE‐DENSE “CARMEN” THERAPY IS BETTER TOLERATED AND EVENLY EFFECTIVE THAN OTHER INTENSIFIED REGIMENS IN HIV‐ AND HIV+ PATIENTS WITH BURKITT LYMHOMA
Hematological Oncology·2025Open Access
286 | THE SHORT‐TERM DOSE‐DENSE CARMEN PROGRAM IS ASSOCIATED WITH BETTER TOLERABILITY AND SIMILAR EFFICACY THAN OTHER INTENSIFIED REGIMENS IN HIGH‐GRADE B‐CELL LYMPHOMAS
Hematological Oncology·2025Open Access
Efficacy of Ultrasound-Guided Injections of Type I Collagen-Based Medical Device for Greater Trochanteric Pain Syndrome: A Pilot Study
Life·2025· 6 citedOpen Access
Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patient
AIDS Research and Therapy·2025Open Access
Evaluation of the Efficacy of a Type I Collagen-based Medical Device in the Infiltrative Treatment of Greater Trochanter Pain Syndrome (GTPS): a pilot study
Preprints.org·2024Open Access
Outpatient Administration of First Cycle Azacitidine-Venetoclax in Acute Myeloid Leukemia Patients Compared to Inpatient Care: Preliminary Results of a Single-Center Retro-Prospective Study
Blood·2024· 1 cited
<scp>Revision</scp> of antifungal strategies <scp>definitions</scp> for invasive fungal infections (proven/probable/possible) in 461 patients with haematological malignancies (<scp>REDEFI</scp>‐<scp>SEIFEM</scp>)
Mycoses·2024· 1 citedOpen Access
Corrigendum: Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiences
Drugs in Context·2024· 1 citedOpen Access
OC-63 CNS relapse risk in HIV-positive patients affected by DLBCL and HGBL – a retrospective study of the musthal cohort
2024Open Access
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
EClinicalMedicine·2024· 29 citedOpen Access
MYC rearrangements in HIV-associated large B-cell lymphomas: EUROMYC, a European retrospective study
Blood Advances·2024· 8 citedOpen Access
Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry
Hematological Oncology·2023· 14 citedOpen Access
A review of prophylactic regimens to prevent invasive fungal infections in hematology patients undergoing chemotherapy or stem cell transplantation
Expert Review of Hematology·2023· 1 cited
Safety and Effectiveness of Intensive Treatments Administered Outside the Intensive Care Unit to Hematological Critically Ill Patients: An Intensive Care without Walls Trial
Journal of Clinical Medicine·2023· 2 citedOpen Access
Safety and Effectiveness of Intensive Treatments Administered Outside the Intensive Care Unit to Hematological Critically Ill Patients: An Intensive Care without Walls Trial
Preprints.org·2023· 1 citedOpen Access
P487: MIDOSTAURIN PLASMA EXPOSURE IN PATIENTS WITH FLT3-MUT ACUTE MYELOID LEUKEMIA UNDERGOING POSACONAZOLE PROPHYLAXIS DURING INDUCTION TREATMENT: A PROSPECTIVE MULTICENTRE STUDY FROM THE SEIFEM GROUP
HemaSphere·2023Open Access
Posaconazole and midostaurin in patients with <scp>FLT3</scp>‐mutated acute myeloid leukemia: Pharmacokinetic interactions and clinical facts in a real life study
Clinical and Translational Science·2023· 5 citedOpen Access
MYC ALTERATIONS IN HIV‐ASSOCIATED B CELL LYMPHOMAS: RESULTS OF “EUROMYC” STUDY (A EUROPEAN RETROSPECTIVE STUDY)
Hematological Oncology·2023Open Access
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
Frontiers in Immunology·2023· 36 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Chiara Cattaneo(30), Livio Pagano(24), Alessandro Busca(23), Francesco Marchesi(18), Francesca Farina(17), Anna Candoni(17), Gianpaolo Nadali(16), Maria Ilaria Del Principe(16), Nicola Fracchiolla(13), Lucia Prezioso(12), Mario Delia(11), Rosa Fanci(11), Marco Picardi(10), Jon Salmanton‐García(9), Jaap A. van Doesum(9), Gabriele Magliano(9), Andreas Glenthøj(9), Ola Blennow(9), Giovanni Paolo Maria Zambrotta(9), Carlo Castagnola(9)